Johan Malmstrom 21st Lancefield International Symposium for Streptococci and Streptococcal Diseases 2022

Johan Malmstrom

Johan Malmström is a distinguished Swedish professor and biomedical researcher based at Lund University, where he leads the Infection Medicine Proteomics group in the Department of Clinical Sciences. He also serves as national director for BioMS, the Swedish infrastructure in biological mass spectrometry, and is a principal investigator in SEBRA, the Lund University Sepsis and Bacterial Resistance Alliance. He received his PhD in Cellular and Molecular Proteomics in 2003, followed by postdoctoral training in the United States and Switzerland. Afterward, Dr. Malmström co-founded Biognosys AG, a biotech company specializing in advanced proteomic technologies, before returning to academia in 2010 to pursue his research at Lund University. As of 2021, he has held the position of Scientific Director for the SciLifeLab Integrated Structural Biology platform, working to advance structural proteomics infrastructures and foster collaborations across Swedish national research facilities like Cryo‑EM, MAX IV, and ESS. Malmström’s work focuses on pioneering mass spectrometry and proteomics methodologies to decode host–pathogen interactions, especially in the context of invasive bacterial diseases such as sepsis and Streptococcus pyogenes infections. In 2025, Johan Malmström received an ERC advanced grant to apply structural proteomics to map protein complexes formed between bacterial proteins and human immune factors, identifying conserved epitopes to guide vaccine designs.